Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 3/20 | 0.74 |
| ▸ | DPP4 | P27487 | 2/20 | 0.74 |
| ▸ | F2 | P00734 | 1/20 | 0.66 |
| ▸ | MAOA | P21397 | 1/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 2/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.48 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oenin SCHEMBL6139047 | 1.00 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL29894980 | 1.00 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL29468973 | 1.00 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL662772 | 1.00 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL29521448 | 1.00 | CD38 (0.74) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL723403 | 0.99 | CD38 (0.73) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL29881103 | 0.99 | CD38 (0.73) | CD38DPP4F2MAOATYR | |
| Oenin SCHEMBL1096836 | 0.99 | CD38 (0.73) | CD38DPP4F2MAOATYR | |
| SCHEMBL676805 | 0.99 | CD38 (0.72) | CD38DPP4F2MAOATYR | |
| SCHEMBL30901362 | 0.98 | CD38 (0.75) | CD38DPP4F2MAOATYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213634-A1 | PREPARATIONS CONTAINING ANTHOCYANINS FOR USE IN THE INFLUENCE OF CARDIOVASCULAR CONDITIONS | MEDPALETT AS (NO) | 2025-07-03 | — | — | US | claimed |
| CN-119413785-A | Color developing card for qualitatively and quantitatively determining fishy smell degradation degree of burdock drug and preparation and use methods thereof | 江苏省农业科学院 | 2025-02-11 | — | — | CN | claimed |
| CN-118813574-A | Application of directional mutation glycosyltransferase in synthesis of galactoside anthocyanin | 浙江大学 | 2024-10-22 | — | — | CN | claimed |
| US-20240156882-A1 | PREPARATIONS COMPRISING PROBIOTIC STRAINS AND ANTHOCYANINS | EVONIK OPERATIONS GMBH (DE) | 2024-05-16 | — | — | US | claimed |
| EP-4301385-A1 | PREPARATIONS COMPRISING PROBIOTIC STRAINS AND ANTHOCYANINS | Evonik Operations GmbH (DE) | 2024-01-10 | — | — | EP | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| US-20230302075-A1 | PREPARATIONS CONTAINING BERRY EXTRACTS FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF VIRAL INFECTIONS CAUSED BY CORONAVIRIDAE | EVONIK OPERATIONS GMBH (DE) | 2023-09-28 | — | — | US | claimed |
| US-11712056-B2 | Extract obtained from several plants for use in the prevention and/or treatment of chronic inflammatory bowel diseases | VALBIOTIS (FR) | 2023-08-01 | — | — | US | claimed |
| EP-3982924-B1 | PLANT EXTRACT MIXTURE FOR USE IN THE PREVENTION AND/OR TREATMENT OF CHRONIC INFLAMMATORY BOWEL DISEASES | VALBIOTIS (FR) | 2023-07-26 | — | — | EP | claimed |
| CN-114137110-B | Detection method for mixing of raw juice sugar rich in anthocyanin | 沈阳农业大学 | 2023-07-25 | — | — | CN | claimed |
| US-20160106793-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | UNIVERSITE CLERMONT AUVERGNE (FR) | 2016-04-21 | — | — | US | claimed |
| US-20130171104-A1 | SYNERGISTIC ACTIVITY OF MODULATORS OF THE NO METABOLISM AND OF NADPH OXIDASE IN THE SENSITIZATION OF TUMOR CELLS | UNIVERSITAETSKLINIKUM FREIBURG (DE) | 2013-07-04 | — | — | US | claimed |
| EP-2547412-A1 | METHODS OF OBTAINING NATURAL PRODUCTS FROM COMESTIBLE FLUIDS AND METHODS OF USE | Rutgers, The State University of New Jersey (US) | 2013-01-23 | — | — | EP | claimed |
| US-20090176718-A1 | Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome | NIH - DEITR | 2009-07-09 | — | — | US | claimed |
| WO-2009059218-A1 | BERRY PREPARATIONS FOR TREATMENT OF DIABETES AND METABOLIC SYNDROME | PHYTOMEDICS, INC. (US) | 2009-05-07 | — | — | WO | claimed |
| US-7462370-B2 | Compositions enriched in anthocyanins | PHENOLICS, LLC (US) | 2008-12-09 | — | — | US | claimed |
| US-20070269536-A1 | COMPOSITIONS ENRICHED IN ANTHOCYANINS | PHENOLICS, LLC (US) | 2007-11-22 | — | — | US | claimed |
| EP-1328282-B1 | EFFICIENT METHOD FOR PRODUCING COMPOSITIONS ENRICHED IN ANTHOCYANINS | PHENOLICS LLC (US) | 2006-05-31 | — | — | EP | claimed |
| US-20050037095-A1 | Compositions enriched in anthocyanins | PHENOLICS, LLC | 2005-02-17 | — | — | US | claimed |
| US-20020055471-A1 | Efficient method for producing compositions enriched in anthocyanins | PHENOLICS, LLC | 2002-05-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106793-A1 | COMPOSITIONS AND METHODS FOR CONTROLING CARBOHYDRATE AND FAT METABOLISM | PLIN3, GYS1, PLIN5 | CD38 348/4885DPP4 1009/4885F2 1238/4885 |
| US-20090176718-A1 | Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome | GPR119, FABP4, GYS2 | CD38 740/4885DPP4 109/4885F2 1393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.